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The production of reactive oxygen species (ROS) exerts an addi-
tional tier of control over tyrosine phosphorylation-dependent
signal transduction by transiently inhibiting the catalytic activity of
specific protein tyrosine phosphatases (PTPs). Hence, the ability to
detect reversible oxidation of PTPs in vivo is critical to understand-
ing the complex biological role of ROS in the control of cellular
signaling. Here, we describe an assay for identifying those PTPs
that are reversibly oxidized in vivo, which utilizes the unique
chemistry of the invariant catalytic Cys residue in labeling the
active site with biotinylated small molecules under mildly acidic
conditions. We have applied this cysteinyl-labeling assay to the
study of platelet-derived growth factor (PDGF) receptor signaling
in an angiomyolipoma cell model. Doing so has allowed us to
detect reversible oxidation of several proteins in response to
sustained PDGF stimulation. As in other cell systems, we have
observed the reversible oxidation of the classical PTP SHP2 and the
tumor suppressor phosphatase PTEN in response to PDGF stimu-
lation. Furthermore, we detected reversible oxidation of members
of two other subclasses of PTPs, the receptor PTP LAR and the
dual-specificity phosphatase MKP1. These data demonstrate the
broad selectivity of the assay, allowing us to detect representatives
of all of the major subgroups of the PTP superfamily. We anticipate
that this cysteinyl-labeling enrichment strategy can be applied
broadly to study reversible oxidation as a mechanism of harnessing
PTP catalytic activity in a variety of signaling pathways.
reactive oxygen species  signal transduction  tyrosine phosphorylation 
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Regulated and localized generation of reactive oxygen species(ROS) creates an oxidative microenvironment important for
optimal tyrosine phosphorylation-dependent signal transduc-
tion. Previous studies have shown that ROS-mediated transient
inhibition of the catalytic activity of members of the protein
tyrosine phosphatase (PTP) superfamily plays a crucial role in
facilitating signal transduction (1–3). The PTP superfamily
consists of 100 genes encoding structurally diverse enzymes,
which are characterized by a conserved catalytic domain and
which all perform phosphoryl hydrolysis by using a cysteinyl-
based nucleophilic core within a conserved signature motif. The
PTP signature motif, HC(X)5R(S/T), creates a unique environ-
ment for the catalytic Cys residue. In this setting, the pKa of the
Cys residue, located at the base of a cleft formed by the extremity
of -sheet 12 and -helix 4 [features named for the structure of
PTP1B (4)], is lowered by the presence of the conserved Arg
residue, in addition to the helix dipole of -4 and microdipoles
generated by backbone atoms in the signature motif (4, 5).
Hence, the Cys residue of the signature motif displays an
unusually low pKa, making it both a good nucleophile at neutral
pH in addition to being highly susceptible to oxidation (6). The
sensitivity of PTPs to inactivation by oxidation or alkylation of
the active-site Cys was recognized early in the characterization
of these enzymes (7).
A substantial body of literature reports the regulated produc-
tion of ROS in response to various cellular stimuli, including
peptide growth factors, cytokines, G protein-coupled receptor
agonists, and stress (8). In such cellular contexts, ROS serve as
second-messenger molecules and cause oxidation of specific
residues in proteins leading to a change in the activity or function
of the oxidized protein. In the case of the PTPs, oxidation
impairs catalysis by abrogating the nucleophilic function of the
active-site Cys residue. In this context, it is important to note that
a recent study, in which the oxidation state of PTP1B in cancer
cells was characterized by mass spectrometry, revealed that this
modification was specific to the catalytic Cys residue (9), high-
lighting the importance of the architecture of the active site in
determining the sensitivity of the catalytic Cys residue in PTPs
to this regulatory modification. For classical PTPs, such as
PTP1B and receptor-like tyrosine phosphatase  (RPTP),
oxidation of the catalytic cysteine to sulfenic acid is followed by
a rapid condensation reaction to yield a cyclic sulfenamide (10,
11); this modification favors reversible inhibition over the irre-
versible oxidation to sulfinic and sulfonic acid. There have been
reports of glutathionylation of PTP1B (12), which may also
contribute to promoting reactivation of the enzyme after oxi-
dation. Other members of the PTP superfamily, such as the
dual-specificity phosphatases (DSPs) PTEN and cdc25C, and the
low-molecular-weight PTP (6), are protected from irreversible
oxidation by forming a disulfide bond with a vicinal cysteine
within the active site. It appears that reversible oxidation has the
potential to be a general mechanism of harnessing PTP activity,
ultimately conferring an additional layer of regulation over
signaling networks.
To devise a sensitive method to enrich and identify oxidized
PTPs that can be applied across the PTP superfamily as a whole,
we have used the low pKa of the invariant catalytic Cys residue
as the basis for a labeling strategy. A three-step method has been
developed in which the reversibly oxidized catalytic Cys residues
are specifically biotinylated (Fig. 1). After a physiological stim-
ulus, cells were lysed under anaerobic conditions in the presence
of iodoacetic acid (IAA), an alkylating agent that was used to
modify covalently the thiolate anion of the active-site Cys in
those PTPs that remained in a reduced state. In contrast, any
PTPs that were oxidized by the localized, stimulus-induced
production of ROS were protected from this irreversible alky-
lation. Lysates were then subjected to buffer exchange on a
size-exclusion chromatography column. In this key step, IAA
was removed, and the addition of a reducing buffer allowed the
oxidized PTPs to be reduced back to the active state, in which
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they may react with biotinylated active-site-directed compounds.
The two biotinylated compounds used were a sulfhydryl-reactive
iodoacetylpolyethylene oxide (IAP) probe or an -bromoben-
zylphosphonate (BBP) activity-based probe. Those PTPs that
were oxidized in the original sample can then be identified after
purification by streptavidin pull-down and visualization with
streptavidin–horseradish peroxidase (HRP). Because the com-
position of the PTP superfamily has been defined, the apparent
molecular mass of the reactive proteins can be used to predict
identity, which can subsequently be tested by immunoblotting for
candidate PTPs.
We have applied this assay to the study of PDGF receptor-
induced signaling in angiomyolipoma cells. We detected PDGF-
induced reversible oxidation of members of both classes of
classical PTPs (receptor-like and nontransmembrane PTPs) and
of two different classes of DSPs (VH1-like and PTEN-like),
which demonstrates the broader sensitivity of this improved
assay compared with preexisting techniques. This three-step
cysteinyl-labeling method for detecting reversible oxidation of
the entire PTP superfamily will help delineate new signaling
cascades and improve our understanding of the complex biology
of ROS signaling in vivo.
Results
Measurement of PTP Oxidation by Using a Sulfhydryl-Reactive Probe
in PDGF-Transformed Angiomyolipoma Cells. Because ROS have
been shown to be important in the regulation of signaling in
response to PDGF (13, 14), we chose to test this assay in a
PDGF-transformed cell system. Angiomyolipomas are benign
tumors of the kidney that express functional PDGF receptors
(PDGFRs). A cell line that was derived from a human angio-
myolipoma, by immortalization after sequential introduction of
SV40 Large T and telomerase (SV7tert), was observed to express
active PDGFR but did not form tumors in nude mice (15).
However, upon constitutive retroviral expression of PDGF-BB,
the cells became tumorigenic (15), which was associated with
increased ROS production and enhanced levels of tyrosine
phosphorylation, in particular on the PDGFR (data not shown).
Considering that members of the PTP superfamily are highly
susceptible to oxidation by the second-messenger molecule
hydrogen peroxide (H2O2), we examined their oxidation in these
angiomyolipoma cell populations by using this modified cystei-
nyl-labeling assay. First, we tested the biotinylated IAP probe,
which reacts via a nucleophilic substitution of the halide group
by the PTP-reactive thiol group, resulting in a stable thioether
bond. As shown in Fig. 2A, in the immortalized cells, in which the
levels of ROS are low, there was minimal labeling of proteins;
however, in the PDGF-BB-transformed cells and tumor-derived
cell populations, several reactive proteins were detected.
Thiols are alkylated in their anionic form. Therefore, these
assays were performed at pH 5.5 to favor the low pKa-reactive
Cys residue that is a characteristic of the active site of members
of the PTP superfamily. When the assay was performed at pH
values closer to the pKa of noncatalytic Cys residues (i.e., 8.5),
the extent of protein labeling overall was increased, but the
apparent specificity observed at pH 5.5 was lost (Fig. 3B).
Characterization of the Source of ROS-Induced PTP Oxidation in
PDGF-BB-Transformed Angiomyolipoma Cells. We tested the effects
of various ROS antagonists, both to ascertain whether the signal
we detected using the cysteinyl-labeling assay in the PDGF-
transformed angiomyolipoma tumor cells occurred as a result of
PDGF-induced oxidation and to identify the potential sources of
cellular ROS. The signal was decreased by N-acetylcysteine
(NAC) and Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin
(MnTMPyP), scavengers of H2O2 and of superoxide, respec-
tively, and was abolished by diphenylene iodonium (DPI) (Fig.
3A). Conversely, a specific inhibitor of complex I (rotenone), and
two specific inhibitors of complex III (myxothiazol and stig-
matellin) of the mitochondrial electron transfer chain were
without effect (Fig. 3B). Thus, signal detection in the assay
requires ROS production, attesting to specificity. Furthermore,
even though the NADPH oxidase (NOX) inhibitor DPI influ-
ences both NOX and the dehydrogenase from complex I, the lack
of effect observed from the other mitochondrial electron trans-
Fig. 1. Schematic outline of the cysteinyl-labeling assay. An active PTP is indicated with the active-site cysteinyl residue as a thiolate anion, representing the
cell at a resting state. (1) After a physiological stimulus, the cells were lysed in a degassed buffer at pH 5.5 containing IAA. The low-pKa Cys residue at the active
site of those PTPs that remained in a reduced state are alkylated, terminally inactivating this pool of PTPs. Conversely, the Cys residues that were oxidized by
second-messenger ROS molecules were protected from irreversible alkylation. (2) IAA was then removed from the lysate by buffer exchange using size-exclusion
spin columns, and the oxidized Cys residues were reduced back to the thiolate ion with DTT. (3) The oxidized PTPs were maintained in pH 5.5 buffers and incubated
with either of two biotinylated, active-site-directed compounds, a sulfhydryl-reactive IAP probe or a BBP activity-based probe. Purification by streptavidin
pull-down and immunoblotting permits identification of ROS-targeted PTPs.
Fig. 2. Detection of reversible PTP oxidation by using a sulfhydryl-reactive
IAP probe. Serum-deprived (16 h) angiomyolipoma cell lines (lanes: 1, SV7tert;
2, SV7tert-PDGF; 3, SV7tertPDGF-Tumor1; 4, SV7tertPDGF-Tumor2) were sub-
jected to the cysteinyl-labeling assay by using biotinylated IAP at pH 5.5 (A) or
pH 8 (B). Biotinylated proteins were purified on streptavidin–Sepharose
beads, resolved by SDS/PAGE, and visualized by using streptavidin–HRP.
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port chain inhibitors suggests that PDGF-induced oxidation may
occur via a NOX-mediated H2O2 production.
Determination of the PTP-Labeling Specificity by Using a Phospho-
nate-Based Probe. To explore further the specificity of the assay
toward PTPs, we tested a second active-site-directed probe,
BBP, in this model (Fig. 4A). Although both IAP and BBP
modify a Cys residue, they do so by distinct mechanisms (Fig.
4B). The BBP probe is a phosphonate-based molecule that has
been shown to display specificity toward PTPs (16). Unlike the
IAP probe, which forms a stable thioether bond with the reactive
thiol group, BBP interacts with the PTP active site as would a
phosphorylated tyrosyl residue in a substrate and forms a
nonhydrolyzable cysteinyl-phosphate bond (16). Therefore, the
specificity of the probes was assessed in each of the cell popu-
lations. Interestingly, a similar pattern of reactive proteins was
observed in both IAP and BBP labeling assays, suggesting that
labeling with two probes possessing different biochemical prop-
erties leads to the detection of oxidized PTPs when the assay is
performed at pH 5.5 (Fig. 4C).
Identification of Reversibly Oxidized PTPs in Angiomyolipoma Cells.
Transduction of angiomyolipoma cells with recombinant retrovi-
rus expressing PDGF-BB triggered a variety of changes in cell
signaling that culminated in a transformed phenotype, some of
which were reversible by PTK inhibitors (15). As a first step to
deciphering these changes in signaling, we undertook the identifi-
cation of PTPs that were targeted by PDGF-induced H2O2 by
performing cysteinyl-labeling assays in parallel on SV7tert and
PDGF-transformed cell populations by using IAP or BBP probes.
There are reports in the literature of oxidation of both SHP-2 and
PTENuponPDGFRsignaling (14, 17). The enrichment of oxidized
PTPs via indirect cysteinyl biotinylation allowed us to confirm
SHP-2 and PTEN as targets of PDGF-induced ROS in these cells
(Fig. 5 A B, E, and F). In addition, previously unrecognized targets
of PDGF-induced oxidation were identified, including the DSP
mitogen-activated protein kinase phosphatase-1 (MKP-1) (Fig. 5C
and G). Furthermore, we detected the reversible oxidation of a
receptor PTP LAR (leukocyte common antigen-related), a mem-
ber of the R2A subtype of receptor-like PTPs (1), in the PDGF-
transformed angiomyolipoma cells (Fig. 5 D and G). These data
highlight the broad selectivity of the assay, which provides the
means to detect reversible oxidation of representatives of all of the
major subgroups of the PTP superfamily.
Oxidation of Receptor-Like PTP- upon Treatment of Angiomyolipoma
Cells with H2O2. Because the oxidation of receptor-like PTPs is not
registered in broad-spectrum assay formats such as the in-gel assay
(18), which depends on renaturation of a catalytically functional
enzyme, we tested further the effectiveness of this cysteinyl-labeling
assay in detecting reversible oxidation of RPTPs in cells. After
exposure of SV7tert cells to H2O2, we observed a time-dependent
enrichment of RPTP, with a peak of cysteinyl-biotinylation at 5
min (Fig. 6). The fact that oxidation of RPTP was only observed
after treatment with H2O2 and not in the PDGF-transformed cells
also attests to the specificity of the assay in its ability to distinguish
oxidation of different RPTPs in response to distinct conditions.
Discussion
The redox machinery that controls the level, half-life, and
subcellular location of ROS is rapidly emerging as a critical
determinant of the fine-tuning of tyrosine phosphorylation-
dependent signal transduction (1, 8). The reversible oxidation/
inactivation of members of the PTP superfamily regulates the
balance between kinase and phosphatase activity and is now
known to contribute directly to an elevation in tyrosine phos-
phorylation in response to a wide variety of physiological stimuli.
At this point, PTPs appear to be the primary targets of ROS
when acting on signal transduction cascades, and we describe
here a cysteinyl-labeling assay that enabled us to enrich and
detect the reversible oxidation of members of the PTP super-
family in vivo. Using cells derived from a human angiomyolipoma
tumor (15), we have shown that sustained PDGF-BB stimulation
led to the reversible oxidation of at least four members of the
PTP superfamily: LAR, SHP-2, PTEN, and MKP-1.
A variety of approaches have been taken to the measurement
of PTP oxidation, each with its own challenges and technical
limitations. These approaches include monitoring changes in
PTP activity in response to ROS (19, 20), which faces the
technical difficulty of maintaining the PTP in a catalytically
active state while leaving its redox status unperturbed after lysis.
In addition, although it is possible to examine changes in activity
of specific PTPs in immunoprecipitates, it is hard to predict
which members of the PTP family to test. There have been
several reports in which alkylating agents have been used to
determine the oxidation status of specific members of the PTP
family. In their pioneering study (21), Rhee and colleagues
demonstrated the EGF-induced oxidation of PTP1B by follow-
ing the decrease in covalent modification of PTP1B by radio-
actively labeled IAA in cell lysates after growth factor stimula-
tion. The assay is based on the fact that upon oxidation the
active-site Cys residue is no longer susceptible to alkylation.
Similar approaches have been applied in other systems (17, 22).
A disadvantage of such a strategy is the fact that it measures
oxidation by following the decrease in labeling of the PTP, which
limits the dynamic range of the assay. Although these approaches
can be applied to specific PTPs through immunoprecipitation,
small changes in oxidation would still be hard to detect. Oxida-
tion of some members of the PTP superfamily, in particular
DSPs, such as PTEN (23) and MKP3 (24), has been followed by
monitoring changes in electrophoretic mobility; however, this
approach is also limited by the requirement for prior knowledge
of the identity of the oxidized PTP. For screening purposes, an
assay format that can be applied across the PTP family as a whole
and measures the appearance of the oxidized form, rather than
a decrease in the reduced form, is required. To date, this has
been addressed with two different approaches.
Fig. 3. Reversible PTP oxidation in PDGF-BB-derived tumor cells. Tumor-
derived PDGF-transformed SV7tert cells were serum-deprived (48 h) and
treated for a 48-h period with (A) 25M DPI, 100M NAC, or 5M MnTMPyP;
or (B) 25M DPI, 10M myxothiazol, 100M rotenone, or 10M stigmatellin,
then subjected to the cysteinyl-labeling assay with the biotinylated IAP probe.
Biotinylated proteins were purified on streptavidin–Sepharose beads, re-
solved by SDS/PAGE, and visualized by using streptavidin–HRP.
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The modified in-gel phosphatase assay is a strategy for
enriching those PTPs that have encountered ROS and become
oxidized, while eliminating the background of those PTPs that
remain in the reduced state (18). This task is achieved by
harvesting cell lysates under anaerobic conditions, to prevent
oxidation after lysis, in a buffer supplemented with an alkylating
agent, which irreversibly inactivates any PTPs in a reduced state.
In contrast, the invariant Cys of oxidized PTPs is protected from
alkylation. The activity of this latter pool of PTPs can be
regenerated and visualized in an in-gel phosphatase assay. It is
this aspect of the approach that presents technical challenges. An
aliquot of cell lysate is subjected to SDS/PAGE in a gel that has
been cast containing a radioactively labeled substrate. Proteins
in the gel are sequentially denatured and then renatured in the
presence of reducing reagents, which restores the activity of
those PTPs in which the active-site Cys had been subjected to
stimulus-dependent oxidation. In contrast, those PTPs that were
not oxidized in response to the initial stimulus and were irre-
versibly alkylated in the lysis step remain inactive and are not
registered in the assay. During the renaturation step, dephos-
phorylation of substrate occurs in the region of the gel imme-
diately surrounding the active PTP proteins. The reaction is then
terminated by staining and destaining of the gel, which is finally
dried and exposed to film. The presence of a PTP is visualized
by substrate dephosphorylation and the appearance of a clear,
white area on the black background of labeled substrate in the
autoradiogram. The success of this approach depends on the
ability of the PTP family members to renature in an enzymat-
ically active form in an SDS/polyacrylamide gel, but the extent
to which they do so varies. In particular, the receptor-like PTPs
are unable to renature in the SDS/polyacrylamide gel, and so
oxidation of this large subgroup of the PTPs cannot be measured
by this approach.
An alternative strategy uses an antibody that recognizes
terminally oxidized PTPs. This antibody was generated against
a short peptide, VHCSAG, representing a consensus sequence
for the conserved signature motif at the active site of members
of the PTP superfamily, in which the Cys residue had been
oxidized to sulfonic acid by treatment with performic acid. The
strategy also involves cell lysis in the presence of IAA, to alkylate
reduced Cys residues, and reduction of any reversibly oxidized
PTPs back to the active state. However, in a separate step, these
PTPs are then terminally oxidized to the sulfonic acid form by
treatment with pervanadate and identified by immunoblotting
with the oxPTP antibodies (25). This approach has been used
successfully to distinguish the susceptibility of different PTPs to
oxidation (26), in particular demonstrating that the second,
membrane-distal PTP domain of RPTP is more sensitive to
oxidation than the membrane-proximal catalytic domain and
may serve as a redox sensor (26). A problem with this approach
is that it would measure not only those PTPs that were subject
to regulation by reversible oxidation, but also register any PTPs
Fig. 4. Comparison of IAP- and BBP- based probes for detection of reversibly oxidized PTPs in PDGF-BB-transformed angiomyolipoma cells. (A) Structures of
biotinylated IAP and BBP probes. (B) Mechanisms of PTP labeling by the IAP and BBP probes. (C) Serum-deprived (16 h) angiomyolipoma cell lines (lanes: 1 and
5, SV7tert; 2 and 6, SV7tert-PDGF; 3 and 7, SV7tertPDGF-Tumor1; 4 and 8, SV7tertPDGF-Tumor2) were subjected to the cysteinyl-labeling assay using either
biotinylated IAP (lanes 1–4) or BBP probes (lanes 5–8). Biotinylated proteins were purified on streptavidin–Sepharose beads, resolved by SDS/PAGE and visualized
by using streptavidin–HRP.
9962  www.pnas.orgcgidoi10.1073pnas.0804336105 Boivin et al.
that were already present in the cell in a terminally oxidized
state. This issue could be significant in cancer cells (9). Other
potential challenges include the specificity and sensitivity of the
antibody. Most of the studies to date that have used this
approach have examined the oxidation of ectopically expressed
classical PTPs (25, 26). It remains to be established whether this
antibody is able to recognize all members of the PTP super-
family, in particular the DSPs, and to what extent it has the
sensitivity to measure oxidation of PTPs at physiological levels
of expression.
The strategy described here overcomes several of the technical
challenges that are encountered with existing methods. As in the
modified in-gel phosphatase assay, lysis under anaerobic conditions
in the presence of an alkylating agent simplifies the mixture by
eliminating any PTPs that have not encountered ROS, thereby
focusing attention on the pool of these enzymes that have been
regulated by reversible oxidation. In replacing the in-gel assay by
labeling with biotinylated probes, we have removed the require-
ment for denaturation/renaturation cycles and activity-based de-
tection, and, consequently, we can now detect the reversible oxi-
dation of receptor PTPs. Because the presence of the sulfhydryl
group as a thiolate ion directly determines the susceptibility to such
labeling, we conducted the assays at a pH close to the pKa of the
PTP catalytic cysteine. By performing the assay under mildly acidic
conditions, side reactions with noncatalytic cysteines and other
amino acids, which have been shown to occur at higher pH,
appeared to be minimized, thereby enhancing specificity. Further-
more, the use of biotinylated active-site-directed probes not only
promotes enrichment of low abundance PTPs, but also permits
detection on a blot with streptavidin–HRP, thereby providing
information on the apparent Mr of the reactive proteins and
facilitating identification by immunoblotting.
Recent progress in defining mechanisms for regulation of
RPTP function has revealed the roles of oxidation of the
membrane-distal (D2) PTP domain both in RPTP dimeriza-
tion and in sensing intracellular redox status (27). RPTP dimer-
ization is thought to be inhibitory to catalytic function. Further-
more, the conformational change induced in the extracellular
segment upon oxidation of the RPTP D2 domain has the
potential to affect ligand binding in an ‘‘inside-out’’ manner.
Hence, it appears that oxidation is an important mechanism of
regulating RPTP function. Using this cysteinyl-labeling assay, we
have been able to detect the reversible oxidation of LAR in
response to PDGF and RPTP in response to treatment with
H2O2 in the angiomyolipoma cells. To our knowledge, this assay
is the first to display a broad sensitivity across all of the PTP
superfamily, including the RPTPs, and should be useful in
clarifying the roles of these enzymes and their oxidation in the
regulation of signal transduction.
The design of specific protein-modifying reagents that can
drive proteomic analyses is a cornerstone of modern functional
studies of distinct enzyme families within a complex proteome.
The pronounced similarity in biotin labeling observed between
the alkylating agent IAP and the PTP active-site-directed probe
BBP suggests that this assay is measuring PTP oxidation effec-
tively in these cells. Furthermore, we have used this assay to
detect PTP oxidation in response to acute stimulation by PDGF
in other cell systems, for example Rat-1 fibroblasts (data not
shown). In the future, the use of BPP as a suicide substrate probe
Fig. 5. Identification of reversibly oxidized PTPs in PDGF-BB-transformed angiomyolipoma cells by using IAP- and BBP-based-probes. Serum-deprived (16 h)
angiomyolipoma cell lines (lanes: 1, SV7tert; 2, SV7tert-PDGF; 3, SV7tertPDGF-Tumor1; 4, SV7tertPDGF-Tumor2) were subjected to the cysteinyl-labeling assay
using either biotinylated IAP (A–D) or BBP probes (E and F). Biotinylated proteins were purified on streptavidin–Sepharose beads, resolved by SDS/PAGE, and
immunoblotted against SHP2 (A and E), PTEN (B and F), MKP-1 (C and G), or LAR (D and H). Reversible PTP oxidation was restricted to PDGF-BB-transformed
angiomyolipoma cells using both probes. WB, Western blotting.
Fig. 6. RPTP reversible oxidation is detected by using the cysteinyl-labeling
assay. Serum-deprived (16 h) angiomyolipoma SV7tert cells were exposed to
200 M H2O2 for 1, 5, or 10 min and subjected to the cysteinyl-labeling assay
using a biotinylated IAP probe. Biotinylated proteins were purified on strepta-
vidin–Sepharose beads, resolved by SDS/PAGE, and immunoblotted by using
anti-RPTP antiserum.
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to enrich PTPs that are reversibly oxidized in vivo may be
integrated into proteomic-based approach to define the specific
pool of reversibly oxidized PTPs in various signaling contexts.
There are small differences in biotin labeling observed between
IAP and BBP, which raises the possibility of other ROS targets
possessing low pKa catalytic Cys residues that may be involved in
signaling networks. It will be interesting to ascertain whether,
and by what mechanism, other ROS-regulated proteins may have
an impact on growth factor-induced signals.
Experimental Procedures
Materials. SHP-2 (sc424) and PTP-LAR (sc25434) antibodies were purchased
from Santa Cruz Biotechnology. Anti-PTEN (9552) was from Cell Signaling Tech-
nology. The MKP-1 antibody was described in ref. 28, and the PTP antibody was
a kind gift from Jeroen Den Hertog (Hubrecht Institute). Zeba desalt spin columns
(89889), IAA(35603),andEZ-link iodoacetyl-PEO(21334)biotinprobeswerefrom
Pierce Biotechnology. Biotinylated BBP was prepared as described in ref. 16.
Preparation of Lysates. Cells were routinely maintained in low-glucose DMEM
supplemented with 10% FBS, 100 units/ml penicillin, and 100 g/ml strepto-
mycin (15). Cells were grown to confluence and serum-starved before lysis as
indicated. Cells were lysed essentially as described in ref. 18. To prevent the
spontaneous oxidation of PTPs through the air oxygen dissolved in solution,
the freshly prepared lysis buffer [25 mM sodium acetate (pH 5.5), 1% Nonidet
P-40, 150 mM NaCl, 10% (vol/vol) glycerol, 25 g/ml aprotinin, 25 g/ml
leupeptin] was degassed at 30–35 in-Hg on a vacuum line for 1 h and placed
on ice. Under these conditions, the pO2 level of the lysis buffer was 0.35–0.50
ppm, and no lysis-induced oxidation was observed. The degassed buffer was
supplemented with freshly prepared 10 mM IAA, 100 g/ml catalase, and
superoxide dismutase (219261 and 574594; Calbiochem) before use. Cell
plates were moved inside an anaerobic work station, purged, and constantly
supplied with ultrapure argon gas for further handling. After removing the
DMEM, cells were rapidly lysed with ice-cold IAA-supplemented degassed
buffer and transferred to brown-colored tubes.
Cysteinyl-Labeling Assay. Lysates were placed on a shaker for 1 h at room
temperature to allow complete alkylation of free thiols. Cell debris were then
cleared by centrifugation at 12,000g for 3 min at room temperature. Protein
concentrations were determined by the method of Bradford, and 1 mg of cell
lysate was slowly applied to desalting columns that had been equilibrated
with IAA-free lysis buffer. Buffer exchange was performed by centrifuging at
2,000 g for 2 min at 4°C. IAA-cleared lysates were then supplemented with
1 mM DTT and allowed to incubate for 30 min on a shaker at room temper-
ature. During this phase, cyclic sulfenamide and sulfenic acid forms of the
active-site Cys residues, which were protected from alkylation in the previous
step, were reduced back to their thiolate states. After this crucial step, the
lysates were incubated with biotinylated BBP (16) or IAP probes (1 mM, 5 mM)
for 1 h on a shaker at room temperature. Biotinylated proteins were enriched
by using streptavidin–Sepharose beads for 16 h at 4°C on a rotating wheel,
with sequential rounds of centrifugation (12,000 g, 1 min, 4°C) using PBS to
wash the beads. The beads were resuspended in 20 l of 4 Laemmli sample
buffer and heated at 90°C for 1 min.
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